Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Available iodine
Kilco (International) Ltd.
QD08AG03
Available iodine
26.7 milligram(s)/millilitre
Teat dip/spray solution
LM: Licensed Merchant as defined in relevant national legislation
Cattle
iodine
Antiseptics
Authorised
2004-06-04
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Lanodip Concentrate Teat Dip 3:1 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE Iodine 26.7 mg (Available Iodine 21.0 mg) For a full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Teat Dip / Spray Solution. A dark brown liquid. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Lactating dairy cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES As an aid in the prevention of mastitis in lactating dairy cattle. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Teat dip cups should be emptied after each milking and washed thoroughly before re-use. Wash and dry udders and teats before next milking. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Do not eat, drink or smoke whilst using the product. Wash hands after use. When the product is being applied through spray equipment avoid working in spray mist. In case of contact with eyes, give prolonged irrigation with clean water and seek medical attention. In case of ingestion, seek medical attention immediately. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _4_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _2_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _1_ _9_ _2_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.6 ADVERSE REACTIONS (FREQUENCY AND SERI Belgenin tamamını okuyun